Skip to content

Axogen AXGN Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$222K+4.7%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's debt issuance cost amortization?
Axogen (AXGN) reported debt issuance cost amortization of $68K in Q1 2026.
How has Axogen's debt issuance cost amortization changed year-over-year?
Axogen's debt issuance cost amortization decreased by 69.1% year-over-year, from $220K to $68K.
What is the long-term trend for Axogen's debt issuance cost amortization?
Over 4 years (2021 to 2025), Axogen's debt issuance cost amortization has grown at a 0.7% compound annual growth rate (CAGR), from $869K to $892K.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).